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ABSTRACT
Background: The high disease burden of Africa, the
emergence of new diseases and efforts to address the
10/90 gap have led to an unprecedented increase in
health research activities in Africa. Consequently, there is
an increase in the volume and complexity of protocols
that ethics review committees in Africa have to review.
Methods: With a grant from the Bill and Melinda Gates
Foundation, the African Malaria Network Trust (AMANET)
undertook a survey of 31 ethics review committees
(ERCs) across sub-Saharan Africa as an initial step to a
comprehensive capacity-strengthening programme. The
number of members per committee ranged from 3 to 21,
with an average of 11. Members of 10 institutional
committees were all from the institution where the
committees were based, raising prima facie questions as
to whether independence and objectivity could be
guaranteed in the review work of such committees.
Results: The majority of the committees (92%) cited
scientific design of clinical trials as the area needing the
most attention in terms of training, followed by
determination of risks and benefits and monitoring of
research. The survey showed that 38% of the ERC
members did not receive any form of training. In the light
of the increasing complexity and numbers of health
research studies being conducted in Africa, this deficit
requires immediate attention.
Outcome: The survey identified areas of weakness in the
operations of ERCs in Africa. Consequently, AMANET is
addressing the identified needs and weaknesses through
a 4-year capacity-building project.
Recent concerted efforts to address the Grand
Challenges in Global Health
12and the 10/90 gap
3
and to achieve the United Nations Millennium
Development Goals (http://www.un.org/millen-
niumgoals/) have contributed to an unprecedented
increase in health research involving humans in
Africa. In the wake of such an increase in health
research on mostly poverty-stricken and poorly
educated populations, given Africa’s weak civic
protection systems, it is imperative that attention
be paid to the ethical review capacity of African
health institutions. Review of research protocols
before implementation is now regarded as one of
the cornerstones of ethical research involving
human participants, and some countries have
made it a legal requirement.
4 Various international
and national guidelines also stipulate that ethical
approval be a prerequisite for the commencement
of research involving humans.
The main purpose of reviewing research protocols
is to ensure that the research meets internationally
acceptable scientific and ethical standards. It would
be unethical for poorly designed research involving
human beings to be approved, since data generated
from such research would not contribute to the
improvement of disease prevention or management.
A holistic approach to reviewing research is critical,
since issues that relate to ethical principles of
autonomy, beneficence, non-maleficence and justice
are equally important. One approach that has been
proposed looks at seven requirements that should be
considered when reviewing protocols, namely, the
valueoftheresearchintermsofpotentialtoimprove
health and/or knowledge, scientific validity in terms
of experimental design, fair selection of participants
in light of the scientific objectives of the research,
favourable risk:benefit ratio with potential benefits
outweighing potential risks, independent ethical
review of the research before implementation,
informed consent that emphasises voluntary parti-
cipation, and respect for the participants recruited.
5
In addition, community engagement has recently
been recognised as a critical activity that helps to
create an amicable relationship between researchers
and the communities from which participants are
drawn and demonstrates respect for communities as
partners in research.
67It is imperative that ethical
review committees (ERCs) that review the protocols
are adequately knowledgeable about all these
requirements; otherwise the welfare of people is
compromised by approval of unethical research or
wrongful rejection of scientifically and ethically
sound research.
Although the requirements could be assessed
during the review process, implementation of
approved research protocols in the field, especially
in developing countries, is bound to encounter
practical challenges that are attributable to socio-
economic factors.
8–13 Thus, ethical approval alone
does not necessarily ensure protection of the safety
and welfare of research participants throughout the
research; hence the need for approved research to be
monitored by ERCs. Ethical review and subsequent
monitoring of health research require adequate
resources and trained ERCs, which are limited in
various ways in most African committees.
Thus, although the majority of countries in
Africa are reported to now have at least some form
of ethical review process in place,
14–16 the operations
of these processes are generally hindered by a
combination of challenges, including scarcity of
resources, inadequate training of members and
poor staffing levels.
14 16 17 For instance, a study on
health research ethics review and needs of institu-
tional ERCs in Tanzania showed that 49% of 45
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review.
18 Milford and colleagues also reported on the extent to
which limited resources available to ethics committees in Africa
could affect preparations for HIV vaccine trials.
17 Another
example is a case study of 12 African ERCs that showed
inadequate training of committee members and shortage of
resources to be some of the major challenges faced by the
committees.
19
In light of the relatively weak ethical review capacity in
Africa, it is encouraging to note that a number of not-for-profit
African organisations are involved in capacity-building pro-
grammes. The South African Research Ethics Training Initiative
(SARETI) (http://shsph.up.ac.za/sareti/sareti.htm), which is
based at the universities of KwaZulu-Natal and Pretoria in
South Africa, provides training in ethics to African researchers
and ERC members through short-term fellowships and long-
term educational programmes. Another programme based in
South Africa is the International Research Ethics Network for
Southern Africa (IRENSA) (http://www.irensa.org), based at
the University of Cape Town, which runs short-term training
programmes for mid-career African academics, scientists,
clinicians and members of ERCs who generally cannot enrol
for long-term, full-time programmes. An additional organisation
involved in providing educational programmes in Africa is the
Training and Resources in Research Ethics Evaluation (TRREE)
(http://www.trree.org/site/en_home.phtml) for Africa, which
focuses on development of research ethics educational pro-
grammes for e-learning and provision of e-resources.
The African Malaria Network Trust (AMANET) (http://
www.amanet-trust.org) is also a not-for-profit organisation
that was formed in 2002, succeeding the then African Malaria
Vaccine Testing Network, founded in 1995 to promote malaria
vaccine trials in Africa. Although the broad objective of
AMANET is still the same as that of its predecessor, the roles
and activities of AMANET have been expanded to include (1)
trial site development for malaria vaccine trials, which entails
infrastructural development and training of research personnel
in various scientific fields, (2) strengthening of ethical review
capacity in Africa and (3) sponsorship of malaria vaccine clinical
trials.
The current study by AMANET was aimed at finding specific
gaps in the ethical review process in Africa with a view to
effectively implementing a capacity-building programme tailor-
made for the identified needs. Having such empirical data would
go a long way towards ensuring that any interventions would
complement efforts by others in this field rather than duplicate
their activities, although a certain amount of overlap is both
inevitable and harmless. The paucity of resources for ethical
review process in Africa and the need to strengthen the process
through various training programmes make it critical for the
organisations working in this field to streamline their activities
and programmes and promote synergistic collaborative efforts.
Indeed, the efforts of the organisations are beginning to bear
fruit. For instance, two ethicists working in the AMANET
programmes are products of the SARETI training programmes,
and an additional ethicist working with AMANET also actively
takes part in both IRENSA and SARETI programmes.
In order to fill the gaps identified by the needs assessment
survey, AMANET targeted ERCs as entities rather than
individual members of the committees, an aspect being
addressed by other organisations. Collaboration with the Pan
African Bioethics Initiative started at the design stage of the
current project and has continued to the implementation stage,
where the two organisations jointly conduct some training
workshops on health research ethics. This paper reports on the
findings of the needs assessment survey and gives an overview
of a longitudinal capacity-building project by AMANET.
METHODS
Information on the capacities and needs of ERCs in Africa was
obtained through presentations by selected ethics committee
members during three workshops organised by AMANET in
Dar es Salaam and in Addis Ababa and a needs assessment
survey conducted across Africa. The data gathered through the
two methods were pooled together for analyses.
Ethics committee presentations at AMANET health research
ethics workshops
Members of ethics committees attending the AMANET series of
health research ethics workshops during 2007 were requested to
present to the workshop participants the status and operations
of their committees. The participants were requested to prepare
presentations covering such issues as the committees’ composi-
tion, standard operating procedures, sources of funding, type of
data management and archiving system, ethical review process
and workload. This allowed interactive discussions on the
shortcomings, strengths and needs of the various committees.
Needs assessment survey
A survey questionnaire, containing 103 questions covering
general identifying information and sections on the establish-
ment of the ERCs, membership and professional background of
members, funding of the committees and ethical review process
for 2005 and 2006 was designed and pilot tested at institutions
in southern Africa, East Africa and West Africa. A French
version of the questionnaire was prepared for use in franco-
phone countries. Six surveyors all qualified in health research
ethics were appointed to conduct physical surveys across sub-
Saharan Africa. The respondents were either the chairpersons or
administrators of the ethics committees surveyed. The com-
pleted questionnaires were compiled and double-entered in
Microsoft Excel and analysed in Stata version 10 (Stata
Corporation, College Station, Texas, USA) by a statistician.
RESULTS
Coverage
A response rate of about 84% (31/37) was achieved, making this
the most comprehensive survey of ERCs in Africa that the
authors are aware of. A total of 12 institutional ERCs from nine
African countries gave presentations at two AMANET health
research ethics training workshops held in Dar es Salaam,
Tanzania (May and August 2007), and a third workshop held in
Addis Ababa, Ethiopia, in September 2007. Gaps and short-
comings of the ERCs were identified and possible solutions
explored during interactive discussions that followed each
presentation. The presentations covered Cameroon, Ethiopia,
Ghana, Kenya, Mali, Malawi, Nigeria, Senegal, Tanzania,
Gambia, Uganda and Zambia. The ERCs that presented were
among the 31 respondents that were interviewed by surveyors.
The countries covered in the survey, which include anglophone,
francophone and lusophone countries, are shown in table 1.
Composition of the ERCs
As shown in fig 1, the ERCs ranged in size from three to 21
members. The 31 ERCs surveyed had a total of 345 members,
the average number of members per committee being 11.
Regarding gender balance, about 33% (112/345) of the members
Research ethics
190 J Med Ethics 2009;35:189–193. doi:10.1136/jme.2008.025189of all 31 committees were female. Ten committees (32%) did
not have any external members (that is, members not affiliated
to the parent institutions where the respective committees were
based). As shown in table 1, a total of seven committees are
national, while seven and 17 are affiliated to universities and
health research institutes, respectively.
Constraints reported by respondents
The top five training needs cited by the respondents were
scientific design of clinical trials, risk assessment of clinical
trials, understanding of trial phases, monitoring of approved
studies, and handling of issues surrounding post-trial access to
benefits. Table 2 shows the major constraints that were
highlighted by the respondents, the top two being inadequacy
of resources available to the committees and limited expertise in
the committees to review complex studies. Other frequently
mentioned constraints were pressure from researchers, weak
participation of members and low rating of the importance of
the functions of ERCs. None of the respondents had electronic
data management and archiving systems in place; they all relied
on cumbersome, paper-based systems.
Duration of training, and training needs of ERCs
Overall, 38% of the members had not undergone any form of
training in health research ethics. Table 3 shows the duration of
training courses attended by the members of the surveyed
committees.
Table 4 shows the training needs of ethics committees. Topics
related to understanding the scientific design of research
protocols in intervention trials were reported as being the
greatest need, while topics related to identification of appro-
priate subjects scored the least. Other important topics
identified include determination of potential risks of vaccines,
trial phase determinants and monitoring/oversight activities.
Independence of ERCs
Membership of 10 committees was entirely by staff employed
at the institution, while the rest had varying involvement of
members from ‘‘outside’’ the parent institution, such as
community members, local universities, religious organisations,
non-governmental organisations, civic organisations and profes-
sional associations. A large proportion (77%) of the surveyed
committees relied on funds received from the institutions where
they were based in 2005 and 2006. Figure 2 shows that a
relatively smaller proportion of respondents received levies on
projects reviewed, whereas application fees were a source of
funding for a much smaller number of committees, about 20%
for both years.
DISCUSSION
This survey covered 31 ERCs of 37 targeted institutions; 12 of
the 31 committees also presented at workshops organised by
AMANET. This is to our knowledge the first survey ever to
cover so many countries and institutions; previous surveys in
Africa have been on a smaller scale and arguably less
comprehensive. Furthermore, this survey included anglophone
Table 1 Number and nature of ethics review committees (ERCs)
surveyed per country
Country
Number of
ERCs Affiliation
Burkina Faso 2 All research-institute based
Cameroon 2 All research-institute based
Ethiopia 2 All research-institute based
Gabon 1 Research-institute based
Gambia 1 National
Ghana 5 4 research-institute based, 1 university based
Kenya 1 National
Malawi 1 University based
Mali 1 University based
Mozambique 1 National
Nigeria 4 1 university based, 3 research-institute based
Rwanda 1 National
Senegal 1 National
Sudan 1 University based
Tanzania 4 1 national, 2 university based, 1 research-institute
based
Uganda 1 University based
Zambia 1 Research-institute based
Zimbabwe 1 National
Total 31
Figure 1 Composition of ethics review committees.
Table 2 Constraints hindering operations of ethics review committees
(ERCs)
Constraints Number of ERCs*
Insufficiency of resources 25/30
Lack of/insufficient expertise on ethical review 13/30
Pressure from researchers 11/30
Lack of active/consistent participation of members 11/30
Lack of recognition of the importance of ERC functions 11/30
None or poorly supported by the institute 10/30
Not completely independent 4/30
Pressure from sponsors 3/30
Unequal treatment of applicants in review 1/27
Biased committee members 0/27
*Respondents skipped some questions.
Table 3 Duration of training of committee members
reported by respondents
Duration of training
Number of committee
members
None 132
1 day 13
2–3 days 42
4–7 days 92
.7 days 48
Online training 14
Not known 4
Total 345
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phone (1) institutions. Although this survey received replies
from most African regions, replies from central Africa were rare.
The relatively high response rate could be attributed to the
personal visits by the surveyors. Encouragingly, only two of the
37 institutions lacked ethics review committees and did not
complete the questionnaire. This is a great improvement from
previous times,
20 when the absence of ethics committees in
many African countries was common.
The World Health Organization publication Operational
guidelines for ethics committees that review biomedical research
(2000) states:
Countries, institutions, and communities should strive to
develop ECs and ethical review systems that ensure the broadest
possible coverage of protection for potential research participants
and contribute to the highest attainable quality in the science
and ethics of biomedical research. States should promote, as
appropriate, the establishment of ECs at the national, institu-
tional, and local levels that are independent, multi-disciplinary,
multi-sectorial, and pluralistic in nature. ECs require adminis-
trative and financial support (p2).
21
The survey shows that most institutions across sub-Saharan
Africa have established ethics committees. However, in order to
effectively review protocols, ERCs should be composed of
members of diverse backgrounds; many ethics committees
surveyed are not yet sufficiently multidisciplinary or multi-
sectoral. There are also weaknesses relating to gender and age.
The UNAIDS (Joint United Nations Programme on HIV/AIDS)
guidelines stipulate that an ERC should have a minimum of five
members, and there is no upper limit that is set by guidelines.
The current study revealed that membership is still problematic
for some ERCs in sub-Saharan Africa, with some having as few
as three members and others 19 or more. The major reasons
cited for the wide variation in membership include unwilling-
ness of potential members to participate in the committees over
and above their normal duties and the lack of compensation for
the costs incurred in attending ERC meetings. These issues need
to be addressed if ERCs are to function properly.
Independence of the committees from their institutions is
influenced by a number of factors. First, a committee made up
of members from the institution that hosts it, without external
members, faces a high risk of bias in its work. Second, reliance
on the parent institution for financial support also compromises
the independence of the ERC. It is therefore imperative that the
ultimate goal should be to enable ERCs to generate adequate
operational funds in order to reduce financial reliance on host
institutions and also to attract members from outside the
parent institution. This is all the more important in sub-
Saharan Africa, given the limited financial and skilled human
resources available and very poor personnel remuneration.
However, the cost of running an ERC needs to be determined,
if cost-effective fees are to be charged to ensure self-sustain-
ability. Although in developed countries such as the USA,
efforts have been made to determine running costs,
22 the
authors are not aware of such attempts made elsewhere,
especially in Africa.
Training of members before or upon joining an ERC would
help to orient them in terms of the standard operating
procedures in place and the ethical review procedures of the
particular committee. Whereas the volume of trials being
conducted in Africa is increasing, 92% of the surveyed
committees reported that they are inadequately trained to
properly review and monitor trials. Since it may not be feasible
for committee members to take long leaves of absence to undergo
long-term training away from their workplaces, workshops and
Table 4 Training needs of ERCs in Africa, ranked by respondents
Training needs
Ranking
Very important Quite important Important Not important Total institutions*
Scientific design issues in intervention trials 27 2 29
Determination of potential risks of malaria vaccine research 25 3 1 29
Determinations to run phases (I,II,III) in a country or community 25 2 1 28
Monitoring and oversight 23 5 1 29
Post-trial access to benefits (eg, successful intervention) 20 6 1 1 28
The interpretation of preclinical studies 19 7 3 29
The use of placebo in controlled trials 16 9 3 1 29
Assessment of understanding for informed consent 16 10 1 1 28
Assessment of anticipated benefits 15 8 5 1 29
Assessment of cultural sensitivity for informed consent 15 9 3 1 28
Community participation 14 11 3 1 29
Determination of appropriate subject selection in vulnerable population1 4 8 5 1 2 8
Determination of appropriate subject selection with regard to women 13 6 8 12 8
Incentives for participation 12 10 5 1 28
Social and behavioural studies 12 10 6 1 29
Privacy and confidentiality 11 13 4 1 29
Determination of appropriate subject selection with regard to minors 11 9 61 2 7
*Some respondents did not answer some questions.
Figure 2 Sources of funds for 31 ethics review committees surveyed.
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towards meeting the training needs of the committees. Despite
the increasing popularity of e-learning, only 4% (14/345) of the
members surveyed have benefited from these opportunities, and
this percentage may even decrease as committees become more
independent, multi-sectoral and pluralistic. Reliance on tradi-
tional pedagogical methods, with all their drawbacks, particularly
in the least-developed countries, may be the only opportunity.
The survey revealed the training needs of ethics committees
in sub-Saharan Africa. A closer examination of the responses is
guiding the development of ongoing training of members of
ethics committees and will be invaluable in the development of
upcoming training of investigators.
Harmonisation of ethical review process
A study conducted in the USA showed variable decisions by
different ERCs that reviewed the same protocol for a multi-
centre genetic epidemiological study.
23 Given the diversity of the
ERCs in Africa, especially the weaknesses cited above, there is a
high likelihood of diverse decisions if study protocols will be
subjected to these committees, particularly in upcoming multi-
centre studies. The need to harmonise ethical review in Africa is
considered to be urgent. The harmonisation could first focus on
procedural aspects of the ethical review process and subse-
quently address substantive aspects of ethical review, which
could be more challenging than the former. However, for the
harmonisation to be acceptable to the African ERCs and also
effective in terms of improving the ethical review process, a
participatory approach that includes all interested stakeholders
is critical.
The survey also highlighted the need for clear roles and
responsibilities of national ERCs in relation to institutional
ERCs in countries where both national and institutional
committees exist. The roles of the committees should be
complementary rather than duplicative; it should be clear to
the committees themselves and to potential applicants what
type of health research protocols should be reviewed by the
respective committees. Such clarity would go a long way
towards minimising potential antagonism between the national
and institutional ERCs of the same country.
CONCLUSIONS
This paper provides useful public information on the status of
ethics committees that stakeholders in biomedical research in
Africa would find useful. The major constraints identified are
shortage of resources and inadequate training of the ERC
members. Sponsors of clinical trials in Africa will also find this a
useful inventory when considering compliance of trial sites to
international recommendations, and it is hoped that the ethical
review process and oversight of research will always be taken
into account at the design stage of research in order to include
the activities in the budget and in the project time frame.
The gaps identified through this survey should be addressed
through dedicated capacity-strengthening providing specifically
identified and tailor-made support to ensure improvement,
instead of conducting such surveys merely for academic
purposes. A careful post-intervention survey using the same
evaluation tools would be important to gauge the effectiveness
of the interventions implemented, and the results should be
widely disseminated for the benefit of the members of the
scientific community who are involved in health research.
Fostering collaborative efforts with other organisations involved
in capacity-building of the ethical review process in Africa could
go a long way towards minimising the risk of duplication of
activities, which would waste resources.
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